The rising prevalence in GLP-1 agonists for metabolic conditions has generated a question about formats: skin-applied devices versus capsules. Typically, GLP-1 treatments were solely available in pill https://kallumpvjs697860.post-blogs.com/61783462/glp-1-transdermal-delivery-systems-vs-tablets-what-suitable-for-the-patient